BRAF and metastatic neoplasm: Upon comparing the single gene analysis results and tumour progressive score between the primary and the resected metastatic tumour, we observed EGFR exon 19 deletion in the both tumour but BRAF V600E mutations only in metastatic tumour (Table 1).